Most B vitamin supplements use precursor forms your body still has to convert. Mantra uses the active versions. Here's what that means.
The label says B12. It doesn't tell you which version.
That gap is where most B vitamin formulas quietly diverge from their promises. The name on the label refers to a family of related compounds, not a single molecule. The version determines whether your body can use the compound directly, or whether it needs to convert it first. That conversion step is where the gap between a good formula and an average one opens up.
Why Form Changes What a Vitamin Does
Vitamin B6 exists in six chemical forms. Only one of them, pyridoxal-5-phosphate, is the active coenzyme the body's enzymes actually require. The others, including pyridoxine hydrochloride, need to be converted in the liver before they can do anything.
That conversion usually works. But it isn't guaranteed. Genetic variants, including MTHFR polymorphisms, reduce enzymatic conversion efficiency. So does compromised liver function. So does age. In those cases, the dose on the label doesn't match the dose that reaches active status.
Vitamin B12 follows the same principle. Cyanocobalamin is the synthetic form found in most supplements. It contains a molecule that must be removed before conversion to an active form can occur. Methylcobalamin is one of those active forms: the one most relevant to neurological function, found naturally in animal tissue, and the version the brain preferentially uses. It crosses the blood-brain barrier more readily and is retained in neural tissue for longer. It doesn't require conversion.
Using the active forms removes the conversion variable entirely. The dose on the label is the dose that reaches active status.
What the Research Shows
A 2016 review in Nutrients examined the role of B vitamins in brain function across a substantial body of published evidence. It found that B6 is directly involved in the synthesis of serotonin, dopamine, and GABA. B12 supports myelin sheath synthesis, the protective coating around nerve fibres that determines how efficiently neurons conduct signals. Both vitamins regulate homocysteine metabolism. Elevated homocysteine is independently associated with cognitive decline.
The P-5-P form of B6 is specifically relevant to neurotransmitter synthesis because it is the direct cofactor the enzymes involved in that process require. Pyridoxine has to be phosphorylated in the liver first. P-5-P is already phosphorylated. For the synthesis of serotonin, dopamine, and GABA, P-5-P is the form the enzyme binds to.
A 2021 paper in Nutrients reviewing clinical evidence on B6 confirmed this: P-5-P has higher bioavailability than pyridoxine in most contexts, and is particularly preferable in populations where conversion efficiency is reduced. The authors concluded the active form is the appropriate choice for clinical formulations.
For methylcobalamin, a 2007 paper in Experimental Biology and Medicine reviewed B12 bioavailability across multiple forms. The evidence showed methylcobalamin is preferentially retained in liver and nervous tissue compared to cyanocobalamin, and is the primary form of cobalamin detected in the brain.
"Of the various forms of vitamin B12, methylcobalamin is the form that is most effective in the nervous system and is the predominant form in the brain."
— Watanabe, F., Experimental Biology and Medicine, 2007
What This Means for Mantra
Mantra contains five B vitamins. In two cases, the form used is the active, end-stage version: 5.1 mg of P-5-P and 100 mcg of methylcobalamin. For the other three, the form decision was also considered.
B1 as Thiamine HCL — 24 mg
Bioavailable salt form. Essential for the glucose-to-energy conversion that powers neural activity.
B3 as Nicotinamide — 40 mg
The NAD+ precursor without the vasodilation that nicotinic acid causes at higher doses. Same outcome, different experience.
B5 as Calcium-D-Pantothenate — 50 mg
Required for coenzyme A synthesis, which the body needs to produce acetylcholine. The neurotransmitter most directly associated with memory encoding and sustained attention.
None of these are label decisions. The sachet is small. Everything inside it is earning its place.
The Takeaway
Using P-5-P and methylcobalamin rather than their cheaper precursor forms costs more to make and adds nothing visible to the label. That's exactly the point. Mantra's B vitamins are there to function, not to appear. The dose on the label should reflect the dose that reaches active status. With these forms, it does.
Try Mantra and see what considered formulation feels like in practice.
Frequently Asked Questions
Does the form of B12 actually matter for most people?
For most people, cyanocobalamin converts adequately. For people with MTHFR variants, gut absorption issues, or compromised liver function, conversion is less reliable. Methylcobalamin bypasses the conversion entirely. It's the reason clinical settings favour it when B12 adequacy matters.
Why is the B12 dose 100 mcg when the RDA is only 2.4 mcg?
B12 absorption is physiologically limited. The gut can only absorb a fraction of any given dose at one time, regardless of the total amount. 100 mcg ensures adequacy even with variable absorption rates. It is not a large dose relative to how B12 actually behaves in the body.
What does B5 have to do with focus?
B5 is required for coenzyme A synthesis, which the body needs to produce acetylcholine. Acetylcholine is the neurotransmitter most directly involved in memory encoding and sustained attention. B5 isn't a stimulant. It's the infrastructure that makes those processes possible.
Why nicotinamide instead of plain niacin for B3?
Both are B3 forms that serve as NAD+ precursors. Nicotinic acid causes vasodilation at higher doses: a hot, flushed feeling lasting 20 to 30 minutes. Nicotinamide delivers the same NAD+ function without triggering it. Same outcome, better experience.
Sources
Kennedy, D.O. (2016). B Vitamins and the Brain: Mechanisms, Dose and Efficacy: A Review. Nutrients, 8(2), 68.
Stach, K., Stach, W., & Augoff, K. (2021). Vitamin B6 in Health and Disease. Nutrients, 13(9), 3229.
Watanabe, F. (2007). Vitamin B12 sources and bioavailability. Experimental Biology and Medicine, 232(10), 1266-1274.